6 taboos about taking Avatrombopag (Avatrombopag, Su Kexin)

Avatrombopag/Avatrombopag (Avatrombopag) is an important drug used to treat thrombocytopenia, especially for patients with chronic liver disease and patients with immune thrombocytopenia who have insufficient response to other treatments. However, there are some contraindications and precautions that patients should pay special attention to when using avatrombopag to ensure safe and effective treatment.

1. Before using avatrombopag, patients need to determine whether they have a history of allergies to the ingredients of the drug. If you have a known allergic reaction, do not use this medicine on your own to avoid causing severe allergic reactions and endangering your health. In addition, patients with abnormal liver function should also be cautious when using avatrombopag, because although this drug is mainly used to manage thrombocytopenia in patients with chronic liver disease, its safety in patients with extremely impaired liver function has not been fully demonstrated. In this case, it is best to conduct evaluation and medication under the guidance of a professional doctor.

2. Avatrombopag may interact with certain drugs, so before using this drug, you should inform your doctor of all the drugs you are currently taking, including prescription drugs, over-the-counter drugs, and herbal supplements. Some drugs may affect the metabolism of avatrombopag, affecting its efficacy or increasing the risk of adverse reactions. Therefore, patients should communicate with their doctors regularly during medication and make medication adjustments when necessary.

3. Dietary habits may also affect the efficacy of avatrombopag. Patients should avoid ingesting large amounts of alcohol at the same time, which may not only cause additional burden on the liver, but may also interfere with the metabolism and action of the drug. In addition, a high-fat diet may also affect drug absorption, so patients are advised to maintain a balanced diet to ensure optimal efficacy of the drug.

4. Some patients may experience fluctuations in platelet count while taking avatrombopag, which requires patients to regularly monitor their blood routine during medication in order to detect potential problems early. If you find that the number of platelets is abnormally high or low, you need to contact your doctor promptly for evaluation and adjustment of the treatment plan.

5. Patients must follow the doctor's instructions while using avatrombopag, and are not allowed to increase or decrease the dose or discontinue the drug at will. On the one hand, this is because inappropriate medication may lead to insufficient efficacy, and on the other hand, it may increase the risk of adverse reactions. If patients experience any abnormal reactions during medication, such as bleeding, bruises, etc., they should seek medical attention immediately.

To sum up, although avatrombopag is widely used as an effective treatment option, patients need to pay attention to the above taboos and precautions during medication to ensure the safety and effectiveness of the treatment. Before taking medication, consulting a professional doctor, following medical advice and regularly monitoring your health will be important steps to ensure successful treatment.

Reference materials:https://www.ema.europa.eu/en/medicines/human/EPAR/doptelet